Results of an interim analysis of a multinational randomized, double-blind, phase III study in patients (pts) with previously treated metastatic colorectal cancer (mCRC) receiving FOLFOX4 and PTK787/ZK222584 (PTK/ZK) or placebo (CONFIRM 2)

• KOEHNE C

収録刊行物

• Proc Am Soc Clin Oncol

  Proc Am Soc Clin Oncol 2006

詳細情報

• CRID: 1574231875336622208
• NII論文ID: 10021938761
• データソース種別:
  • CiNii Articles